Networth Advisors
ABCL icon

Networth Advisors’s AbCellera Biologics ABCL Stock Holding History

Networth Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$329K Hold
22,526
– – 0.19% 50
2026
Q2 		$177K Buy
+22,526
New +$110K 0.1% 61

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Networth Advisors's ABCL Position: Q3 2026 in Review

Networth Advisors held its AbCellera Biologics (ABCL) position steady in Q3 2026 at 22,526 shares worth $329K. The position accounts for 0.19% of the portfolio, ranked #50.

Networth Advisors first reported a position in ABCL in Q2 2026 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • Networth Advisors held 22,526 shares of AbCellera Biologics worth $329K as of Q3 2026.
  • Networth Advisors left its AbCellera Biologics share count unchanged in Q3 2026.
  • AbCellera Biologics made up 0.19% of Networth Advisors's portfolio in Q3 2026, its #50 holding.
  • Networth Advisors first reported a position in AbCellera Biologics in Q2 2026 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on Networth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.